Schrödinger, Inc. SDGR
$14.91
▼ -1.03% 24H
About
Schrödinger, Inc. develops a physics-based computational platform that enables the discovery of novel molecules for drug development and materials applications. The company operates in two primary segments: Software and Drug Discovery. The Software segment provides advanced computational tools to biopharmaceutical and …
SectorHealthcare
ExchangeNASDAQ
IndustryHealth Information Services
CountryUnited States
Employees850
TickerSDGR
Statistics
Market Cap$1.11B
Revenue (TTM)$255.9M
Net Income-$103.3M
Net Margin-40.4%
EPS$-1.41
P/E44.39
P/S4.24
P/B3.44
EV/EBITDA-4.96
ROE-30.1%
Dividend Yield—
Price$14.91
Data: Twelve Data · Revenue = mcap / P/S